Department of Orthopedic Surgery, General Hospital of Chinese People's Liberation Army, Beijing 100853, China.
Chin Med J (Engl). 2011 Dec;124(23):3968-75.
Connective tissue growth factor (CTGF) is a secreted protein containing several domains that mediate interactions with growth factors, integrins and extracellular matrix components. CTGF plays an important role in extracellular matrix production by its ability to mediate collagen deposition during wound healing. CTGF also induces neovascularization in vitro, suggesting a role in angiogenesis in vivo. We herein evaluated whether CTGF was required for extracellular matrix synthesis of meniscal fibrochondrocytes and/or angiogenesis during the repair of meniscal tears.
Meniscal fibrochondrocytes were isolated from the inner-1/2 of rabbit meniscus by trypsin collagenase treatment and further treated with 100 ng/ml CTGF in vitro. Characterization of fibrochondrocytes was identified by flow cytometry analyzing CD31, CD44, CD45 and CD105, and was further tested by type II collagen immunocytochemistry. Changes in gene expression of meniscal fibrochondrocytes were monitored by quantitative real-time polymerase chain reaction. Histological sections prepared from a 3-mm portion of a longitudinal tearing defect in the middle of the rabbit meniscus were subjected to fluorescence-immunohistochemistry analysis at 1, 4 and 10 weeks following surgical treatment with 1.5 µg of CTGF/fibrin-glue composites.
Quantitative RT-PCR assay showed that types I and II collagen and vascular endothelial growth factor mRNA expression in the 100 ng/ml CTGF group were remarkably enhanced as compared to levels in the no-dose group at 14 days ((2.38 ± 0.63) fold, (2.96 ± 0.87) fold, (2.14 ± 0.56) fold, respectively). Likewise, fluorescence-immunohistochemical analysis revealed that in the group implanted with CTGF-fibrin glue, types I and II collagen, as well as the capillaries, completely filled the defect by 10 weeks, postoperatively. In contrast, only soft tissue repair occurred when PBS-fibrin glue was implanted.
These findings suggest that CTGF can significantly promote extracellular matrix deposition (types I and II collagen) within the meniscal avascular zone; CTGF can greatly heighten the expression of vascular endothelial growth factor activity simultaneously in vivo, further enhancing the repair of meniscal tears in the avascular zone.
结缔组织生长因子(CTGF)是一种分泌蛋白,含有几个结构域,介导与生长因子、整合素和细胞外基质成分的相互作用。CTGF 在伤口愈合过程中通过介导胶原蛋白沉积在细胞外基质产生中发挥重要作用。CTGF 还在体外诱导新血管生成,表明其在体内血管生成中起作用。本研究旨在评估 CTGF 是否在半月板纤维软骨细胞的细胞外基质合成和/或半月板撕裂修复过程中的血管生成中起作用。
通过胰蛋白酶胶原酶处理从兔半月板内 1/2 中分离半月板纤维软骨细胞,并在体外进一步用 100ng/ml CTGF 处理。通过流式细胞术分析 CD31、CD44、CD45 和 CD105 来鉴定纤维软骨细胞的特征,并通过 II 型胶原免疫细胞化学进一步测试。通过定量实时聚合酶链反应监测半月板纤维软骨细胞的基因表达变化。在手术治疗后 1、4 和 10 周,从兔半月板中间的 3mm 纵向撕裂缺陷的一部分制备组织学切片,并进行荧光免疫组织化学分析,使用 1.5μg CTGF/纤维蛋白胶复合物。
定量 RT-PCR 分析显示,与无剂量组相比,100ng/ml CTGF 组在 14 天时 I 型和 II 型胶原和血管内皮生长因子 mRNA 表达明显增强(分别为 2.38±0.63、2.96±0.87、2.14±0.56 倍)。同样,荧光免疫组织化学分析显示,在植入 CTGF-纤维蛋白胶的组中,I 型和 II 型胶原以及毛细血管在术后 10 周时完全填满了缺陷。相比之下,当植入 PBS-纤维蛋白胶时仅发生软组织修复。
这些发现表明 CTGF 可显著促进半月板无血管区的细胞外基质沉积(I 型和 II 型胶原);CTGF 可同时在体内显著提高血管内皮生长因子活性的表达,进一步增强半月板无血管区撕裂的修复。